efficient unfolding through Bausch + Lomb’s proprietary StableFlex ™ Technology, which aids optic recovery. For patients with astigmatism, enVista Aspire Toric IOLs provide a proven option for ...

InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration ...

Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy ...

Bausch + Lomb launched the enVista Aspire monofocal and toric IOLs in the European Union, according to a press release.Using intermediate optimized optics, the lenses offer a range of vision beyond ...

Bausch + Lomb (BLCO) announced the commercial launch of the enVista Aspire monofocal and toric intraocular lenses in the European Union after receiving a CE Mark late last year. enVista Aspire ...

Like enVista MX60E, enVista Aspire offers a glistening-free optic material and controlled, efficient unfolding through Bausch + Lomb’s proprietary StableFlex ™ Technology, which aids optic recovery.